- Kurt thought there was a 50% chance all GLP-1 compounding would end in the next 6 months (both 503A and 503B) - Did not mention direct communication from the FDA telling them to stop compounding GLP-1s - ProRx felt it was time to stop due to the end of the shortage in March 2025, and did not feel influenced by the April 1 FDA statement - Kurt thinks 503B production of GLP-1s are underreported and much larger than thought - 503As can't take care of the compounded GLP-1 market at their current capacity - We both have concerns about patient access without compounded GLP-1s and worry it will send more patients to the grey market for RUO injections that don't have the same level of sterility and regulation To view or add a comment, sign in Every year, innovators rush into GLP studies before they're truly ready
The agency advises patients, wholesalers, retail pharmacies and health care professionals to check the Ozempic products they have received and not use, distribute or sell products labeled with lot number PAR0362 and serial number starting with the first eight digits 51746517 as pictured below
Glutathione gip trung ha cc gc t do gy hi, bo v t bo da v lm chm tc lo ha mt cch t nhin. Glutathione cn c v nh i v s quan trng ca ln da, gip phc hi cc tn thng do tia UV hay cc tc nhn mi trng gy ra
Who Should Choose TrimRx TrimRx makes the most sense for patients who want a single, predictable monthly price without a separate membership fee
Let's be honest about what actually works, what doesn't, and what might put your health at risk
Burn2O is the worlds FIRST and ONLY liquid thermogenic to combine MitoBurn, CaloriBurn, L-Carnitine and GBB into a delicious calorie-free liquid shot, creating a super thermogenic fat burner that boosts V02 max and optimizes brain function
